FDA Clearance Tracker · P040029-S017
Orthokeratology (tisilfocon A) Contact Lenses for Overnight Wear
Last checked: Nov 20, 2026Latest source record: Mar 30, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Mar 30, 2021
Approved
Time to decision
172 days
Received Oct 9, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P040029-S017
- Device name
- Orthokeratology (tisilfocon A) Contact Lenses for Overnight Wear
- Applicant
- Euclid Vision Corporation
- Applicant location
- Sterling, VA
- Received
- Oct 9, 2020
- Decided
- Mar 30, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P040029
Device type
- Device class
- Class III
- Regulation
- 21 CFR 886.5916
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for model name additions to the Euclid Systems Orthokeratology (tisilfocon A) Contact Lenses for Overnight Wear
Source documents
Other decisions for Euclid Vision Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.